Potassium-Sparing Diuretics
(Redirected from Spirotone)
Potassium-Sparing Diuretics are a subclass of diuretics that do not promote the excretion of potassium, unlike other classes such as loop or thiazide diuretics. This category includes Amiloride, Eplerenone, Spironolactone, and Triamterene. These agents serve a critical role in the management of various medical conditions, primarily those associated with fluid retention.
Introduction[edit | edit source]
In general, diuretics promote the removal of excess fluid from the body by increasing urine production. However, many diuretics also cause the body to excrete potassium, leading to potential problems such as hypokalemia. The potassium-sparing diuretics, as their name suggests, are designed to counteract this problem.
Amiloride[edit | edit source]
Amiloride, a pyrazinoylguanidine derivative, acts on renal epithelial sodium channels, thereby promoting sodium excretion with minimal impact on potassium levels. This action results in its potassium-sparing feature. While similar in action to Triamterene, its chemical structure differs.
- Clinical Usage: It is used for edema management, especially when combined with thiazide diuretics. Given its modest diuretic effect, it's frequently paired with a thiazide diuretic, like hydrochlorothiazide in Moduretic, utilizing its potassium-sparing property to balance the potassium-wasting effect of thiazides.
- Adverse Effects: Side effects may include hyperkalemia, headache, dizziness, gastrointestinal upset, and rash.
- Availability and Dosage: Available generically and under the brand Midamor in 5 mg tablets. Typically, doses range from 5 to 20 mg daily.
Eplerenone[edit | edit source]
A competitive aldosterone antagonist, Eplerenone has a strong affinity for aldosterone receptors in the kidneys. This bond leads to sodium diuresis while preserving potassium levels, vital in conditions like hypertension and post-myocardial infarction heart failure.
- Clinical Usage: Primarily used for hypertension management and heart failure post-myocardial infarction.
- Adverse Effects: Eplerenone may cause hyperkalemia, transient increases in serum aminotransferase levels, and serum creatinine elevation.
- Availability and Dosage: Offered generically and under the brand name Inspra in 25 and 50 mg tablets. Initial doses are 25 or 50 mg daily, with maintenance doses between 25 and 100 mg daily.
Spironolactone[edit | edit source]
A well-established aldosterone antagonist, Spironolactone acts by inhibiting the mineralocorticoid receptor in the kidneys. Its ability to modulate sodium and potassium exchange makes it valuable for managing edematous states, especially those induced by hyperaldosteronism such as in cirrhosis.
- Clinical Usage: Predominantly used for edema management in conditions like cirrhosis, it's also combined with other diuretics to counterbalance their potassium-wasting effects.
- Adverse Effects: Its antiandrogen-like effects can lead to side effects like hair growth and gynecomastia.
- Availability and Dosage: Available under the brand Aldactone and generically in multiple strengths. Doses range from 25 mg daily up to 450 mg daily based on clinical need.
Triamterene[edit | edit source]
Triamterene targets sodium channels in the renal tubules, promoting sodium diuresis and retaining potassium. This action profile makes it a choice for edema management, often alongside other diuretics.
- Clinical Usage: Used in edema therapy, it can be safely prescribed for cirrhosis patients and combined with other diuretics to minimize hypokalemia risks.
- Adverse Effects: Common side effects encompass dizziness, fatigue, headache, dry mouth, and hyperkalemia.
- Availability and Dosage: Available as Dyrenium and generically in 50 and 100 mg tablets or capsules. Typical doses range between 50 and 200 mg daily.
Summary[edit | edit source]
Potassium-sparing diuretics hold a pivotal role in numerous therapeutic scenarios. Their ability to retain potassium while promoting diuresis makes them a preferred choice, especially when potassium imbalances are a concern.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD